Open Access

Cardiovascular effects of glucagon-like peptide 1 receptor agonists.

Congress Session

About the speaker

Doctor Mansoor Husain

University of Toronto, Toronto (Canada)
7 presentations
1 follower

3 more presentations in this session

Glucagon-like peptide 1 receptor agonists & cardiovascular outcomes: What have we learned?

Speaker: Doctor M. Cavender (Chapel Hill, US)


Glucagon-like peptide 1 receptor agonist use in cardiology.

Speaker: Professor M. Petrie (Glasgow, GB)


Live panel discussion.


Access the full session

Exploring the latest evidence of cardiovascular benefits with glucagon-like peptide 1 receptor agonists

Speakers: Doctor M. Husain, Doctor M. Cavender, Professor M. Petrie

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

Open Access

What should we do when we are presented with an individual who has CVD and comorbid obesity?

27 August 2021

Open Access

What treatment options can cardiologists offer people with CVD and obesity?

27 August 2021

Open Access

Welcome and introduction.

27 August 2021

This platform is supported by

logo Novo Nordisk